查詢結果分析
來源資料
相關文獻
- Argon Laser Trabeculoplasty in Primary Open-Angle Glaucoma: A Five-Year Follow-up
- Corneal Opacity and Congenital Glaucoma Associated with Massive Heparan Sulfaturia: Report of One Case
- 碳酸酐酶抑制劑6-Hydroxyethoxy-2-benzothiazole Sulfonamide靜脈注射後之兔眼藥物動力學
- 碳酸酐酶抑制劑6-Hydroxyethoxyzolamide局部點眼後之兔眼藥物動力學
- Carteolol (Arteoptic[feb9])之臨床評估及心血管作用--內因性擬交感神經作用之探討
- Timoptol-XE[feb9] 及Timoptol[feb9] 用於青光眼或高眼壓症病人之比較性研究
- 抑制細胞增生藥物在青光眼濾過造口術的應用
- 雅鉻雷射虹膜穿孔術於急性隅角閉鎖性青光眼的臨床結果
- 藥物導致的青光眼
- Dorzolamide(Trusopt[feb9])--第一個Carbonic Anhydrase Inhibitor眼滴劑
頁籤選單縮合
題名 | Argon Laser Trabeculoplasty in Primary Open-Angle Glaucoma: A Five-Year Follow-up=氬氣雷射小樑網成型術於原發性開放性青光眼:五年追蹤報告 |
---|---|
作者 | 吳秀琛; 鄭珣; | 書刊名 | 中華民國眼科醫學會雜誌 |
卷期 | 34:2 1995.06[民84.06] |
頁次 | 頁40-45 |
分類號 | 416.748 |
關鍵詞 | 氬氣雷射小樑網成型術; 青光眼; Argon laser trabeculoplasty; Primary open angle glaucoma; |
語文 | 英文(English) |
中文摘要 | 本研究探討氫氣裔射小樑網成型術應用於原發性開放性青光眼的長期 降壓效果。5I雙患眼於接受雷射治療後均至少追踩五年以上。五年後的成功率為 52.9咪。平均眼壓下降分別為第一年5.9mmHg;第二年7.4血mHg;第三年6.2mmHg; 第四年5.7m血Hg;第五年5.9mmHg。這些變化和術前基礎眼壓比較均具有統計 學的意義(p<0.001)。影響雷射手術成功因素分別是年齡和術前的基礎眼壓。此外 本研究並顯示同一患者的兩隻眼睛於接受氬氣小樑網成型術其效果具有一致性 (p<0.01)。亦即第一隻眼睛的術後成果可以預測另一隻眼睛的成敗與否。 |
英文摘要 | Long-germ efficacy of argon laser trabeculoplasty was evaluated infifty-one eyes with uncontrolled primary open angle glaucoma. The overallsuccess rate at the end of five years is 52.9. The mean decrease of IOPin the treated eyes was 5.9 mmHg at one year, 7.4 mmHg at two years, 6.2mmHg at three years, 5.7 mmHg at four years, and 5.9 mmHg at five years.These changes from baseline were all statistically significant (p < 0.001).The favorable factors for success were older age and lower prelaser baselineIOP. It is also found that success or failure of the ALT in the first treatedeye predicts similar result in the fellow eye. |
本系統之摘要資訊系依該期刊論文摘要之資訊為主。